Advertisement

The New Realities of Global Health: Dynamics and Obstacles

  • Marine Buissonnière
Part of the International Development Policy book series (IDP)

Abstract

The past 15 years have seen the arrival of new actors in the field of global health and an increase in development aid in the healthcare sector. These actors have claimed a significant share of the additional public and private resources available becoming the driving force in this new paradigm, often at the expense of traditional institutions, which have gradually lost their policy hegemony. Making choices and formulating policies on the matter of healthcare have ceased to be the sole prerogative of the institutions that had hitherto held the mandate and the responsibility for doing so. Entire areas of the healthcare sector are now dominated by private funders, which have become the de facto decision-makers on public health policy. This new situation raises fundamental questions about governance and accountability. Who decides policy? How are decisions made? All too often, countries in receipt of aid continue to suffer from inadequate coordination between donors and from the lack of a common agenda. With this in mind, it is worth exploring a number of ways of ensuring that global healthcare policies best reflect the beneficiary countries’ actual needs and aspirations.

Keywords

Global Health Healthcare Sector Private Partnership Healthcare Policy Donor Country 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. AFP (Agence France Presse) (2011) L’OMS ouvre sa 64 e Assemblée sur fond d’austérité budgétaire et de réforme, 5 May.Google Scholar
  2. AidWatch (2011) Between Austerityand Political Will: EU MS ODA Budgets in 2011, February.Google Scholar
  3. Balabanova, D., M. McKee, A. Mills, G. Walt and A. Haines (2010) ‘What Can Global Health Institutions Do to Help Strengthen Health Systems in Low Income Countries?’, Health Research Policy and Systems, 8(22), DOI 10.1186/1478–4505-8–22.Google Scholar
  4. Benkimoun, P. (2011) ‘La complaisance à l’égard d’un laboratoire peut miner une institution’, Le Monde, 23–24 January.Google Scholar
  5. Birdsall, N. and B. Deese (2004) ‘Hard Currency: Unilateralism Doesn’t Work for Foreign Aid Either’, Washington Monthly, March, http://www.washingtonmonthly.com/features/2004/0403.birdsall.html (accessed on 22 April 2011).
  6. Birn, A.E. (2005) ‘Gates’s Grandest Challenge: Transcending Technology as Public Health Ideology’, The Lancet, 366(9484), pp. 514–19, DOI 10.1016/S0140–6736(05)66479–3.CrossRefGoogle Scholar
  7. Buse, K. and A.M. Harmer (2007) ‘Seven Habits of Highly Effective Global Public-Private Health Partnerships: Practice and Potential’, Social Science and Medicine, 64, pp. 259–71.CrossRefGoogle Scholar
  8. Chow, J.C. (2010) ‘Is the WHO Becoming Irrelevant?’, Foreign Policy, 8 December.Google Scholar
  9. Delaunay, S. (2011) Etats des lieux de l’infection VIH en république de Centrafrique et piste de réflexion pour MSF, MSF internal report, April.Google Scholar
  10. De Torrenté, N. (2009) The Global Health Landscape: Mapping Trends and Developments of Relevance to MSF, MSF internal report, June.Google Scholar
  11. DFID (Department for International Development) (2007) The International Health Partnership Launched Today, 5 September, http://webarchive.nationalarchives.gov.uk/+/http://www.dfid.gov.uk/Media-Room/News-Stories/2007/The-International-Health-Partnership-Launched-Today/ (accessed on 15 April 2011).Google Scholar
  12. Doughton, S. and K. Heim (2011) ‘Does Gates Funding of Media Taint Objectivity?’, The Seattle Times, 19 February, http://seattletimes.nwsource.com/html/localnews/2014280379_gatesmedia.html (accessed on 5 May 2011).
  13. Duparc, A. (2011a) ‘L’OMS face à un nouveau conflit d’intérêts’, Le Monde, 23–24 January.Google Scholar
  14. Duparc, A. (2011b) ‘L’Organisation mondiale de la santé, une agence de plus en plus privée’, Le Monde, 19 May.Google Scholar
  15. England, R. (2007) ‘Head to Head: Are We Spending too much on HIV?’, British Medical Journal, 334(7589), DOI 10.1136/bmj.39113.402361.94.Google Scholar
  16. Fay, S. (2011) ‘Les “philanthropes” confisquent l’action publique’, Le Nouvel Observateur, 31 March–6 April.Google Scholar
  17. Fidler, D.P. (2007) ‘Architecture amidst Anarchy: Global Health’s Quest for Governance’, Global Health Governance, 1(1), http://www.ghgj.org/Fidler_Architecture.pdf (accessed on 4 October 2011).
  18. Gates, B. (2009) 2009 Annual Letter from Bill Gates: The Role of Foundations (Seattle: Bill&Melinda Gates Foundation), http://www.gatesfoundation.org/annual-letter/2009/Pages/2009-role-of-foundations.aspx (accessed on 4 October 2011).Google Scholar
  19. GFATM (Global Fund to Fight AIDS, Tuberculosis and Malaria) (2011) Making a Difference. Global Fund Results Report2011 (Geneva: GFATM).Google Scholar
  20. GHW (Global Health Watch) (2008) Global Health Watch 2: An Alternative World Health Report (London and New York: Zed Books).Google Scholar
  21. HAI (Health Action International) (2011) Statement on Conflicts of Interest Delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN, 20 May, http://haieuropestaffblog.blogspot.com/2011/05/statement-on-conflicts-if-interest. html (accessed on 23 May 2011).Google Scholar
  22. Hanefeld, J. and M. Musheke (2009) ‘What Impact Do Global Health Initiatives Have on Human Resources for Antiretroviral Roll-Out? A Qualitative Policy Analysis of Implementation Processes in Zambia’, Human Resources for Health, 7(8), DOI 10.1186/1478–4491-7–8.Google Scholar
  23. HLTF (High Level Task Force on Innovative Financing for Heath Systems) (2009) Working Group 1: Constraints to Scaling Up and Costs, final draft, 5 June.Google Scholar
  24. IHME (Institute for Health Metrics and Evaluation) (2010) Financing Global Health 2010: Development Assistance and Country Spending in Economic Uncertainty (Seattle, WA: IHME).Google Scholar
  25. Kamal-Yanni, M. and D. Berman (2011) Erring on the Side of the Poor and not Profits, http://www.msfaccess.org/main/vaccines/erring-on-the-side-of-the-poor-and-not-profits, 6 July (accessed on 12 July 2011).Google Scholar
  26. KEI (Knowledge Ecology International) (2009) Wikileaks Documents Related to the WHO EWG, 9 December, http://keionline.org/node/ (accessed on 5 May 2011).Google Scholar
  27. Martens, J. (2007) Multistakeholder Partnerships: Future Model of Multilateralism? Dialogue on Globalization no. 29, occasional paper (Berlin: Friedrich-Ebert-Stiftung).Google Scholar
  28. McCoy, D., G. Kembhavi, J. Patel and A. Luintel (2009) ‘The Bill and Melinda Gates Foundation’s Grant-Making Programme for Global Health’, The Lancet, 373(9675), pp. 1645–53, DOI 10.1016/S0140–6736(09)60571–7.Google Scholar
  29. McDonald, R. and R. Horton (2009) ‘Trade and Health: Time for the Health Sector to Get Involved’, The Lancet, 373(9660), pp. 273–4, DOI 10.1016/S01406736(08)61773–0.Google Scholar
  30. McNeil, D. (2008) ‘Gates Foundation’s Influence Criticized’, The New York Times, 16 February.Google Scholar
  31. McNeil, D. (2011) ‘Gates Calls for a Final Push to Eradicate Polio’, The New York Times, 31 January.Google Scholar
  32. Murray, C., B. Anderson, R. Burstein, K. Leach-Kemon, M. Schneider, A. Tardif and R. Zhang (2011) ‘Development Assistance for Health: Trends and Prospects’, The Lancet, 378(9785), pp. 8–10, DOI 10.1016/S0140–6736(10)62356–2.CrossRefGoogle Scholar
  33. PEPFAR (United States President’s Emergency Plan for AIDS Relief) (2011) PEPFAR Funding: Investments That Save Lives and Promote Security, http://www.pepfar.gov/press/80064.htm (accessed on 22 April 2011).Google Scholar
  34. Price, J.E., J.A. Leslie, M. Welsh and A. Binagwaho (2009) ‘Integrating HIV Clinical Services into Primary Healthcare in Rwanda: A Measure of Quantitative Effects’, AIDS Care, 21(5), pp. 608–14.CrossRefGoogle Scholar
  35. Ravishankar, N., P. Gubbins, R.J. Cooley, K. Leach-Kemon, C.M. Michaud, D.T. Jamison and C.J.L. Murray (2009) ‘Financing of Global Health: Tracking Development Assistance for Health from 1990 to 2007’, The Lancet, 373(9681), pp. 2113–24, DOI 10.1016/S0140–6736(09)60881–3.CrossRefGoogle Scholar
  36. Richter, J. (2004) Public-Private Partnerships and International Health Policy-Making: How Can Public Interests Be Safeguarded? (Helsinki: Ministry for Foreign Affairs of Finland, Development Policy Information Unit).Google Scholar
  37. ROA (Reality of Aid) (2010) Aid and Development Effectiveness: Towards Human Rights, Social Justice and Democracy(Quezon City: IBON Books), http://www.realityofaid.org/roa-reports/index/secid/375/part/1 (accessed on 22 April 2011).Google Scholar
  38. Shiffman, J. (2008) ‘Has Donor Prioritization of HIV/AIDS Displaced Aid for Other Health Issues?’, Health Policy and Planning, 23(2), pp. 95–100, DOI 10.1093/heapol/czm045.CrossRefGoogle Scholar
  39. Spicer, N., D. Bogdan, R. Brugha, A. Harmer, G. Murzalieva and T. Semigina (2011) ‘“It’s Risky to Walk in the City with Syringes”: Understanding Access to HIV/AIDS Services for Injecting Drug Users in the Former Soviet Union Countries of Ukraine and Kyrgyzstan’, Globalization and Health, 7(22), DOI 10.1186/1744–8603-7–22.Google Scholar
  40. Sridhar, D. and R. Batniji (2008) ‘Misfinancing Global Health: A Case for Transparency in Disbursements and Decision-Making’, The Lancet, 372(9644), pp. 1185–91, DOI 10.1016/S0140–6736(08)61485–3.CrossRefGoogle Scholar
  41. Stuckler, D., S. Basu and M. McKee (2011) ‘Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?’, PLoS Med, 8(4), DOI 10.1371/journal.pmed.1001020.Google Scholar
  42. Stuckler, D., L. King, H. Robinson and M. McKee (2008) ‘WHO’s Budgetary Allocations and Burden of Disease: A Comparative Analysis’, The Lancet, 372(9649), pp. 1563–9, DOI 10.1016/501406736(08)61656–6.CrossRefGoogle Scholar
  43. The Economist (2011) ‘The End of AIDS? Fighting Transmission’, The Economist, video, 3 June, http://www.economist.com/blogs/multimedia/2011/06/end-aids (accessed on 10 June 2011).
  44. The Lancet (2009) ‘What Has the Gates Foundation Done for Global Health?’, The Lancet, 373(9675), p. 1577, DOI 10.1016/S0140–6736(09)60885–0.CrossRefGoogle Scholar
  45. UNIS (United Nations Information Service) (2000) Security Council Holds Debate on Impact of AIDS on Peace and Security in Africa, press release, 11 January, UNIS/SC/1173 (New York: United Nations).Google Scholar
  46. Walt, G. and K. Buse (2000) ‘Partnership and Fragmentation in International Health: Threat or Opportunity?’, Tropical Medicine and International Health, 5(7), pp. 467–71, DOI 10.1046/j.13653156.2000.00596.x.CrossRefGoogle Scholar
  47. Walton, D.A., P.E. Farmer, W. Lambert, F. Léandre, S.P. Koenig and J.S. Mukherjee (2004) ‘Integrated HIV Prevention and Care Strengthens Primary Health Care: Lessons from Rural Haiti’, Journal of Public Health Policy, 25(2), pp. 137–58.CrossRefGoogle Scholar
  48. WHO (World Health Organization) (2010a) The Future of Financing for WHO, report of an informal consultation convened by the Director-General, WHO/DGO/2010.1 (Geneva: WHO).Google Scholar
  49. WHO (2010b) Voluntary Contributions by Fund and by Donor for the Financial Period 2008–2009, A63/INF.DOC./4 (Geneva: WHO).Google Scholar
  50. World Health Organization Maximizing Positive Synergies Collaborative Group (2009) ‘An Assessment of Interactions between Global Health Initiatives and Country Health Systems’, The Lancet, 373(9681), pp. 2137–69, DOI 10.1016/S0140–6736(09)60919–3.CrossRefGoogle Scholar

Copyright information

© Graduate Institute of International and Development Studies 2012

Authors and Affiliations

  • Marine Buissonnière

There are no affiliations available

Personalised recommendations